CEL-SCI CorpAdd to My Watchlist

CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.63
    Last
  • 0.01  1.30%
    Today's Change
  • 0.62
    Previous Close
  • Today
     
    0.53
    1.23
    52 Week Low - High
8:04 pm ET 7/31/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding112 million
Market Cap$71 million
Return on Equity ttm-781.05%
Last DividendCVM:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.461
EPS: Year Est. 9/15 ttm--
 
EPS: Quarterly Actual 3/15 -0.10
EPS: Quarterly Est. 6/15 --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-60.00
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Revenue$264,030
Net Income$-27 million
Total Assets$19 million
Employees44
Web Sitewww.cel-sci.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!